The Oncology Institute Prof. Dr. Ion Chiricuţă

• Home
• News
• Contact

• For patients
  • Location
  • Making an appointment
  • Administrative steps
  • Ambulatory care
  • Hospitalization
    • Your admission
    • Prepairing your discharge
  • Visiting schedule
  • Departments
    • Clinical sections
    • The Pharmacy
    • The Operating Department
    • The Laboratories
  • The medical staff
  • Services
    • Hospital care services
    • Medical services
    • Psychological services
  • Patients' rights and obligations
    • Designating a person of trust
    • Information and consent
  • Pacient guidelines
• Physicians and researchers
  • Clinical sections
    • Intensive care unit
    • Surgery I Department
    • Surgery I ORL
    • Surgery II Department
    • Surgery II Gynecology Department
    • Surgery II Urology Department
    • Medical Oncology Department
    • Hematology Department
    • Onco-pediatrics Department
    • Radiotherapy I Department
    • Radiotherapy II Department
    • Radiotherapy III Department
  • Laboratories
    • Medical analysis laboratory
    • Radiology and Medical Imaging Laboratory
    • Nuclear Medicine
    • Anatomical pathology Laboratory
    • Functional Genomics, Proteomics and Experimental Pathology Laboratory
    • Radiotherapy, Tumor and Radiobiology Laboratory
  • Translational research
  • Genetic explorations
  • Epidemiology and Biostatistics Department
  • Therapeutic committees
• About us
  • History and mission
  • General information
  • ISO Accreditation
  • Events
  • The Oncology Association „Ion Chiricuţă”
  • The management
    • The board of directors
• Research
  • About the Research Department
  • Biobank
  • The office for technological transfer and innovations
  • Scientific meetings
  • Publications of the Oncology Institute
  • Research projects
    • Norway Grants
  • The projects' web pages
    • BREAST-OMICS RO
    • CERVIX-array
    • IDEI 2
    • BILATHUROM
    • HUMAIN RESSOURCES - PD TYPE
    • BILATSLOVROM
    • IL-15 and HDAC inhibitors in leukemia
    • Dual targeting of VEGFA and PDGFb in cervical cancer: a possible antiangiogenic therapeutic tool using receptor specific CPPs
    • IZERZO
    • Cervicall-arsen-array
    • BREAST-STEM-RES
    • IDEI 1
  • Clinical Trials
  • Radiotherapy, Tumor and Radiobiology Laboratory
    • Presentation of the laboratory
    • Personnel
    • Scientific projects
  • Epidemiology and Biostatistics Laboratory
    • Cancer prevention and Control Coalition
  • Department of Functional Genomics, Proteomics and Experimental Pathology
    • Presentation of the Department
    • Research services Genomics
    • Infrastructure
    • Staff
  • The Department for genetic explorations
  • Platform for interdisciplinary research in oncology
• Cancer prevention and control center
  • Regional Cancer Registry
    • Reports of the Regional Cancer Registry
• Education and training
  • Oncology Department
  • Continuous medical education